Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingNot Applicable A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of the Safety, Tolerability, and Analgesic Efficacy of Ketorolac Tromethamine Administered Intranasally for the Acute Treatment of Migraine - ROX-2007-01
100 Clinical Results associated with ROXRO Pharma, Inc.
0 Patents (Medical) associated with ROXRO Pharma, Inc.
100 Deals associated with ROXRO Pharma, Inc.
100 Translational Medicine associated with ROXRO Pharma, Inc.